The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,520.31 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the delivery of insulin glargine-yfgn U100 pens and has a completion date of February 12, 2024. Amerisourcebergen Drug Corp, located in Conshohocken, Pennsylvania, provides a wide range of pharmaceutical products and medical supplies to U.S. government agencies, particularly the Department of Defense, through various DLA contract vehicles. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract for Amerisourcebergen to deliver pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this contract award.
Generated 5/12/24, 9:04 AM